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Abstract
Flavonoids are bioactive compounds found in foods such as tea, red wine, fruits and vegetables. Higher intakes of speciﬁc ﬂavonoids, and
ﬂavonoid-rich foods, have been linked to reduced mortality from speciﬁc vascular diseases and cancers. However, the importance
of ﬂavonoid-rich foods, and ﬂavonoids, in preventing all-cause mortality remains uncertain. As such, we examined the association of intake of
ﬂavonoid-rich foods and ﬂavonoids with subsequent mortality among 93 145 young and middle-aged women in the Nurses’ Health Study II.
During 1 838 946 person-years of follow-up, 1808 participants died. When compared with non-consumers, frequent consumers of red wine,
tea, peppers, blueberries and strawberries were at reduced risk of all-cause mortality (P< 0·05), with the strongest associations observed for
red wine and tea; multivariable-adjusted hazard ratios 0·60 (95% CI 0·49, 0·74) and 0·73 (95% CI 0·65, 0·83), respectively. Conversely, frequent
grapefruit consumers were at increased risk of all-cause mortality, compared with their non-grapefruit consuming counterparts (P< 0·05).
When compared with those in the lowest consumption quintile, participants in the highest quintile of total-ﬂavonoid intake were at reduced
risk of all-cause mortality in the age-adjusted model; 0·81 (95% CI 0·71, 0·93). However, this association was attenuated following
multivariable adjustment; 0·92 (95% CI 0·80, 1·06). Similar results were observed for consumption of ﬂavan-3-ols, proanthocyanidins and
anthocyanins. Flavonols, ﬂavanones and ﬂavones were not associated with all-cause mortality in any model. Despite null associations at the
compound level and select foods, higher consumption of red wine, tea, peppers, blueberries and strawberries, was associated with reduced
risk of total and cause-speciﬁc mortality. These ﬁndings support the rationale for making food-based dietary recommendations.
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Flavonoids represent a structurally diverse group of polyphenolic
compounds which are synthesised during plant metabolism(1)
and are present in many commonly consumed foods(2).
Particular fruits and vegetables, such as blueberries, apples,
spinach and onions are considered rich sources of ﬂavonoids.
So too are beverages, such as tea and red wine(3).
Meta-analyses have shown that consumption of ﬂavonoid-rich
foods are associated with reduced risk of cause-speciﬁc
mortalities such as those attributable to cancer, diabetes and
CVD(4–7). Much of the beneﬁcial effects of these foods have been
attributed to their high content of biologically active ﬂavonoids,
which have been shown to improve nitric oxide homoeostasis
and endothelial function, and reduce platelet aggregation and
oxidative stress(8–13). Flavonoids are also thought to play roles in
inactivating carcinogens, inducing antiproliferation, cell cycle
arrest and apoptosis, and inhibiting angiogenesis(14).
Despite this growing evidence for reduced risk of speciﬁc
cancer and CVD mortalities associated with consumption of
ﬂavonoid-rich foods, the relationship of ﬂavonoid-rich food and
ﬂavonoid-compound intake with risk of all-cause mortality is less
clear. Following the advent of the comprehensive US Department
of Agriculture ﬂavonoid-class food content database in 2007(15),
the few studies exploring the relation of ﬂavonoid intake
with all-cause mortality have yielded inconsistent patterns of
association, likely due to insufﬁcient sample size, limited variation
in intake or incomplete food composition table(16–18).
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The varying levels of ﬂavonoid-class intake and different
patterns of ﬂavonoid-class intake across countries(19) have also
likely contributed to the lack of clarity regarding the relationship
between ﬂavonoid-compound intake and risk of all-cause
mortality in the population. Furthermore, the role that the
whole food, as distinct from the isolated food constituent,
plays in the relationship with all-cause mortality is yet to be
elucidated. We have recently shown that a higher intake of total
ﬂavonoids, as well as individual ﬂavonoid classes, was associated
with lower risk of CVD, cancer and all-cause mortality in elderly,
postmenopausal women(16). Therefore, this study sought to
explore the relationship between the consumption of ﬂavonoid-
rich foods, and ﬂavonoid compounds, and the risk of all-cause
mortality in a cohort of young and middle-aged US women.
Methods
Participants
In 1989, 116 430 women aged between 25 and 42 years, were
enrolled into the Nurses’ Health Study II. Baseline for this
analysis was 1991, where 93 145 participants had complete
dietary intake data and were free of previous myocardial
infarction, angina, stroke and cancer. The institutional review
board at Brigham and Women’s Hospital reviewed and
approved this study, and participants provided implied consent
by virtue of questionnaire return.
Mortality ascertainment
Mortality incidence were identiﬁed through reports from family
members and postal authorities, allowing ascertainment of an
estimated 98% or more of all deaths(20). Further mortality cases
were identiﬁed through the National Death Index. Using data
from death certiﬁcates and medical records, a physician blinded
to exposure intake classiﬁed causes of mortality according to
the eighth and ninth revisions of the International Classiﬁcation
of Diseases (ICD)(21,22).
Deaths attributable to CVD were deﬁned using the ICD8
codes 390-458 (ICD9 390-459) and cancer mortalities were
those with ICD8 codes ranging from 140 to 207 (ICD9 140-208).
The other-cause mortality variable refers to all mortalities not
attributable to CVD or cancer based on ICD8 codes.
Dietary intake assessment
At baseline (1991) and every subsequent 4 years until
2007, participants completed a semi-quantitative FFQ. From
this, habitual daily intake, in mg/d, of total-ﬂavonoids and
ﬂavonoid classes was estimated using previously described
methods(23). Flavonoid classes in this analysis include: (i) ﬂavonols;
(ii) ﬂavan-3-ols (including catechins and epicatechins, and exclud-
ing proanthocyanidins); (iii) proanthocyanidins; (iv) ﬂavones;
(v) ﬂavanones; and (vi) anthocyanins. Frequency of consumption
of ﬂavonoid-rich foods were recorded as number of servings
per day, week or month(24).
As an indicator of adherence to a healthy dietary pattern, the
Alternative Healthy Eating Index score was calculated using
methods previously described(25).
In order to reﬂect long-term dietary intake, and to minimise
effects of within-person variation, ﬂavonoid exposure
was considered the cumulative average of ﬂavonoid intake,
updated with every 4-year FFQ return. To account for potential
alterations in dietary patterns following a major illness
diagnosis, the primary ﬂavonoid exposure was computed
by suspending dietary intake updates following reported diag-
noses of stroke, heart disease, angina, or cancer, although
follow-up continued until death or the end of the study period
at 2009.
Risk factor assessment
At baseline, and every 2 years thereafter, participants completed
questionnaires on lifestyle, medical conditions, medications and
family medical history.
Statistical analysis
Analyses for habitual consumption of ﬂavonoid-rich foods
based on categories of consumption from the FFQ; ranging
from non-consumers to frequent consumers, as deﬁned as
consuming the food more than once per week. Exposure of
total-ﬂavonoid or ﬂavonoid-class consumption was divided into
quintiles. Hazard ratios and 95% CI for risk of all-cause, and
cause-speciﬁc, mortalities were estimated using age-adjusted
and multivariable-adjusted Cox proportional-hazards models.
P values for trend were calculated with the use of the Wald test
of a score variable based on the median consumption level for
each quintile of ﬂavonoid consumption.
The multivariable-adjusted model included age, BMI, smoking
status, menopausal status, family history of diabetes/cancer/
myocardial infarction, multivitamin supplement use, aspirin use,
race, type 2 diabetes, hypercholesterolaemia, hypertension,
physical activity, alcohol consumption and energy intake.
The multivariable plus diet-adjusted model incorporated
the multivariable-adjusted model plus the Alternative Healthy
Eating Index (minus alcohol) score(26).
For sensitivity analyses, baseline ﬂavonoid intake and unrest-
ricted cumulative average ﬂavonoid intake, where updates con-
tinued until death or end of study irrespective of chronic disease
diagnosis, were also computed. To address the concern that
occult chronic diseases in the years that preceded diagnosis may
have inﬂuenced dietary intake, we excluded the ﬁrst 2 years of
follow-up data and added a 2-year lag period between ﬂavonoid-
intake assessment and each follow-up period.
We conducted several additional sensitivity analyses to assess
the robustness of the results. To minimise the inﬂuence of
smoking or an extremely low or high BMI on the results,
we excluded participants who had ever smoked or who had a
BMI of <18·5 or >40 kg/m2. We also excluded participants
who had diabetes at baseline, and we suspended updating
of dietary variables after a diagnosis of diabetes during study
follow-up.
Analyses were performed with the SAS statistical package
(version 9·3; SAS Institute Inc.). Statistical tests were two-sided,
and P values of <0·05 were considered to indicate statistical
signiﬁcance.
Flavonoid-rich foods and mortality 1471
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517001325
Downloaded from https:/www.cambridge.org/core. University of East Anglia, on 03 Jul 2017 at 14:29:35, subject to the Cambridge Core terms of use, available at
Results
Cohort characteristics
At baseline, the mean age of participants was 36·1 (SD 4·7) years,
with a mean BMI of 24·6 (SD 5·3) kg/m2. Over the 18-year
(1 838 904 person-year) follow-up, there were 1894 deaths.
Cancer was the leading cause of mortality in this cohort,
accounting for 47% (n 887) of all deaths. CVD contributed
10% (n 189) to all follow-up mortalities, and the remaining
818 (43%) mortalities comprised the other-cause mortality
group. The majority of other-cause mortalities were due to
infections (n 182, ICD8 000-136), diseases of other endocrine
glands (n 192, ICD8 250-258) and diseases of the nervous
system (n 315, ICD8 320-358).
Mean daily total-ﬂavonoid consumption was 379 (SD 374)mg.
proanthocyanidins contribute 57%, and ﬂavan-3-ols 28%, to
total-ﬂavonoid intake (Table 1).
Participants were similar in terms of baseline risk factors
across all levels of total-ﬂavonoid consumption. However, high
ﬂavonoid consumers were more physically active and were less
likely to be current smokers at baseline (Table 2).
Flavonoid-rich foods and risk of all-cause and
cause-speciﬁc mortality
We explored potential whole-food contributors by analysing
foods rich in the ﬂavonoid classes (Fig. 1). Frequent
consumption of blueberries, strawberries, apples, peppers, red
wine and tea were all signiﬁcantly inversely associated with
risk of all-cause mortality in age-adjusted, multivariable-
adjusted and multivariable-plus-diet-adjusted models. When
compared with non-consumers, frequent tea and red wine
consumption showed the greatest magnitude of reduction
in risk. Conversely, when compared with infrequent consumers,
risk of all-cause mortality was greater in participants with
frequent grapefruit consumption. Continuing to update of
intake irrespective of chronic disease diagnosis did not sub-
stantially impact results, and results were similar in all sensitivity
analyses.
In cause-speciﬁc age and multivariable-adjusted analyses
(Table 3), when compared with non-consumers, the beneﬁt of
frequent blueberry and strawberry consumption was restricted
to cancer mortality, and the beneﬁt of peppers restricted to
mortalities from other causes.
Although not associated with all-cause mortality, frequent
orange fruit consumers were at reduced risk of cancer
and other-cause mortalities, respectively. Congruent with the
all-cause mortality results, we observed that frequent grapefruit
consumers were at increased risk of mortalities from other
causes.
Both red wine and tea showed the greatest magnitude of
beneﬁt in the all-cause mortality analyses. Speciﬁcally, in the
multivariable-adjusted model, when compared with the non-
consumers, the relative risk of all-cause mortality for frequent
consumers of red wine and tea (more than once per week)
was 0·60 (95% CI 0·49, 0·74) and 0·73 (95% CI 0·65, 0·83),
respectively. When looking at cause-speciﬁc mortalities, fre-
quent consumption of red wine and tea was associated with
reduced risk of both cancer and other-cause mortalities, in both
age-adjusted and multivariable-adjusted models. Results were
not signiﬁcantly altered in sensitivity analyses.
Flavonoid compounds and risk of all-cause and
cause-speciﬁc mortality
In age-adjusted models, participants in the highest quintile of
total-ﬂavonoid consumption were 19% (7–29%) less likely to
have died in the 18-year follow-up period, when compared
with those in the lowest quintile (Table 4). Similar beneﬁcial
associations were observed with increased consumption
of ﬂavan-3-ols, ﬂavonols, ﬂavones, proanthocyanidins and
anthocyanins, however, relationships were attenuated and no
longer statistically signiﬁcant following multivariable adjust-
ment. Despite multivariable adjustment substantially attenuating
the relationships for proanthocyanidins and anthocyanidins, no
one factor in the multivariable-adjusted model was responsible
for attenuation of the ﬁndings. Results were not signiﬁcantly
altered in sensitivity analyses.
We then examined the relation of individual ﬂavonoid
classes with cause-speciﬁc mortality. In age-adjusted models,
when compared with the lowest quintile, participants in the
highest quintile of anthocyanin intake were at lower risk of
mortality from cancer, CVD and other causes. This beneﬁcial
association remained for cancer mortalities following multi-
variable adjustment (Table 5). Flavan-3-ols and proanthocya-
nidins followed a similar inverse pattern, whereas ﬂavonols,
Table 1. Baseline total-flavonoid and flavonoid-class consumption, and
frequency of consumption of major whole food contributors*
(Mean values and standard deviations; n 93 145)
Level of consumption
(mg/d)
Major whole food
Mean SD contributors
Total flavonoids 379 374 Tea
Apples
Oranges†
Flavonoid classes
Flavonols 19 13 Tea
Onions
Apples
Flavan-3-ols 61 82 Tea
Apples
Blueberries
Proanthocyanidins 257 278 Tea
Apples
Strawberries
Flavones 2 1 Oranges†
Red wine
Peppers
Flavanones 33 33 Oranges†
Grapefruit†
Red wine
Anthocyanins 11 14 Blueberries
Strawberries
Apples
* Results are energy adjusted.
† Includes both fresh fruit and juice products.
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ﬂavanones and ﬂavones showed no association in either the
unadjusted or multivariable-adjusted models, with any of the
mortality types.
Discussion
This prospective cohort study of middle-aged US women found
that participants with higher intakes of speciﬁc ﬂavonoid-rich
foods, namely blueberries, strawberries, peppers, red wine and
tea, were associated with reduced risk of all-cause mortality.
When exploring contributors to these relationships, the asso-
ciation with all-cause mortality appeared to be largely driven by
mortalities from cancer, as well as other causes. These bene-
ﬁcial relations did not extend to the other ﬂavonoid-rich foods,
or intakes of ﬂavonoid compounds.
Despite null associations at a compound level, numerous
signiﬁcant associations with all-cause mortality were observed
for many ﬂavonoid-rich foods. Our ﬁnding of a null association
of total-ﬂavonoid intake with risk of all-cause mortality in US
women is congruent with the Iowa Womens’ Health Study(17).
However, in our previous analysis in Australian women(16) we
observed a strong relation between increased total-ﬂavonoid
intake and reduced risk of all-cause mortality. This incon-
gruence in ﬁndings between studies, and the differences we
observed in associations with compounds and whole foods, is
likely explained by the complexity of ﬂavonoid-intake assess-
ment and regional differences in the compositional variation in
the whole food sources of dietary ﬂavonoids(19), which in turn
shapes the pattern of over 4000 different ﬂavonoid compounds
consumed on a daily basis(27).
When looking at whole-food associations, we observed that
increased consumption of blueberries, strawberries, peppers,
red wine and tea was associated with reduced risk of all-cause
mortality. These associations remained after adjusting for
Risk of all-cause mortality
0.5 0.75 1.51
Tea
Red wine
Peppers
Onions
Strawberries
Blueberries
Apples
Grapefruit
Orange juice
Orange fruit
Fig. 1. Multivariable-adjusted risk of all-cause mortality by flavonoid-rich foods,
comparing non-consumers (referent group) with frequent consumers (more than
once per week). Values are hazards ratios and 95% CI. Multivariable-adjusted
model includes: age, BMI, smoking status, menopausal status, family history of
diabetes, cancer and myocardial infarction, multivitamin supplement use, Aspirin
use, race, type 2 diabetes, hypercholesterolaemia, hypertension, physical
activity, energy intake, alcohol consumption and the Alternative Healthy Eating
Index (minus alcohol) score. The person-years (non-consumers, frequent
consumers) for each of the food items are as follows: orange fruit (310336,
452010); orange juice (231 916, 916 036); grapefruit (725397, 329 583); apples
(100840, 974 249); blueberries (868779, 110744); strawberries (221774,
350689); onions (168 378, 499571); peppers (320691, 501045); tea (353257,
1 067188); red wine (1181732, 150 932). Total number of all-cause mortalities
is 1894.
Table 2. Baseline characteristics of the cohort stratified by quintiles of total-flavonoid consumption*
(Mean values and standard deviations; percentages)
Quintile 1 (<150mg/d) Quintile 3 (222–<329mg/d) Quintile 5 (≥587mg/d)
Mean SD Mean SD Mean SD
n 18617 18 612 18 651
Demographic variables
Age (years)† 36·0 4·7 36·0 4·7 36·5 4·6
BMI (kg/m2) 25·0 5·7 24·4 5·1 24·7 5·3
Caucasian (%) 93·1 93·6 94·7
Current smoker (%) 18·1 9·9 11·3
Postmenopausal (%) 3·2 3·1 3·9
Physical activity (MET-h/week) 16·8 24·2 22·6 28·1 21·6 28·8
Prevalent disease
Type 2 diabetes (%) 1·0 1·0 1·0
Hypercholesterolaemia (%) 11·3 10·1 10·9
Hypertension (%) 6·4 6·0 7·0
Family history of disease
Diabetes (%) 17·2 16·0 17·4
Myocardial infarction (%) 22·7 20·7 22·2
Cancer (%) 22·7 22·9 22·2
Dietary intake and medications
Current aspirin use (%) 11·7 10·7 12·0
Current multivitamin use (%) 38·6 47·1 42·7
Energy intake (kJ/d) 7126·2 2262·7 7746·3 2294·9 7260·9 2366·9
Energy intake (kcal/d) 1703·2 540·8 1851·4 548·5 1735·4 565·7
Alcohol intake (g/d) 3·1 6·4 3·3 5·9 2·6 5·6
AHEI (score) 40·8 10·1 45·5 10·4 44·9 10·5
MET, metabolic equivalent; AHEI, Alternative Healthy Eating Index (excluding alcohol) score.
* Values standardized to the age distribution of the study population. Flavonoid consumption is standardised to total energy intake. n 93145.
† Value is not age adjusted.
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dietary pattern, suggesting that the relations are not explained
by their contribution to a healthy dietary pattern. Furthermore,
our results are supported by clinical trial data showing effects of
these foods in improving endothelial function, nitric oxide
status, blood pressure and platelet function, and by reducing
oxidative stress and inﬂammation(28–32). The strongest bene-
ﬁcial relation with all-cause mortality was observed with the
frequency of red wine consumption, which remained even after
adjusting for total alcohol consumption, which has been shown
to be a strong predictor of all-cause mortality(33). When looking
at cause-speciﬁc mortalities, the strongest associations for with
red wine were observed with reduced risk of cancer and other-
cause mortalities, in both unadjusted and multivariate-adjusted
models. The lack of beneﬁcial association with CVD may be
due to the cohort characteristics itself, namely the low CVD
mortality rate in this middle-aged female population.
In contrast to the beneﬁcial whole foods listed above, which
are rich sources of ﬂavan-3-ols, proanthocyanidins and antho-
cyanins, the foods rich in ﬂavanones showed markedly different
results. Oranges showed no association with all-cause mortality,
and grapefruit had a small positive association with all-cause
mortality. This inverse association may be due to the contribution
of sugar-rich juices to total grapefruit intake. Furthermore, this
detrimental association may also be explained by be due to the
ﬁndings that grapefruit components have clinically signiﬁcant
interactions with drugs, which appear to be independent of their
ﬂavonoid content(34). However, this hypotheses were unable to
be explored in this cohort.
We observed that ﬂavonoid-rich whole foods, and not
ﬂavonoid subclasses, showed the strongest associations with
risk of all-cause mortality. Although not reaching statistical
signiﬁcance, many of the ﬂavonoid subclasses followed similar
trends to that of their predominant whole food constituents. For
example, the positive and null associations of ﬂavanone-
rich grapefruit and oranges, respectively, were reﬂected in a
non-signiﬁcant trend in the multivariate-adjusted model
whereby high ﬂavanone consumers tended to have higher
mortality rates. Conversely, the beneﬁcial associations of
anthocyanin-rich blueberries and strawberries was reﬂected in a
no-signiﬁcant observed trend high anthocyanin consumers
tended to have lower mortality rates. The role of the whole-food
in inﬂuencing relationships has not yet been fully elucidated,
and results from the literature are conﬂicting. In understanding
the strength of association differences at a whole food level as
Table 3. Multivariable-adjusted risk of mortality subtypes by flavonoid-rich foods, comparing non-consumers (referent group) with frequent consumers
(more than once per week)
(Hazard ratios (HR) and 95% confidence intervals; n 93145)
Cancer mortality (≥once per week)* CVD mortality (≥once per week)† Other cause (≥once per week)§
HR 95% CI HR 95% CI HR 95% CI
Orange fruit consumption
Age adjusted 0·75 0·60, 0·95 0·66 0·41, 1·07 0·79 0·64, 0·97
Multivariable adjusted‡ 0·76 0·60, 0·98 0·89 0·54, 1·48 0·98 0·78, 1·24
Orange juice consumption
Age adjusted 0·90 0·72, 1·13 0·76 0·48, 1·21 0·83 0·68, 1·03
Multivariable adjusted‡ 0·96 0·76, 1·21 0·89 0·55, 1·43 0·97 0·78, 1·21
Grapefruit consumption
Age adjusted 1·01 0·83, 1·22 0·72 0·48, 1·08 1·19 1·00, 1·42
Multivariable adjusted‡ 1·07 0·88, 1·31 0·92 0·60, 1·42 1·47 1·22, 1·77
Apple consumption
Age adjusted 0·63 0·47, 0·84 0·74 0·37, 1·48 0·60 0·45, 0·79
Multivariable adjusted‡ 0·68 0·50, 0·93 1·19 0·58, 2·45 0·84 0·63, 1·14
Blueberry consumption
Age adjusted 0·67 0·50, 0·89 0·41 0·19, 0·89 0·77 0·60, 1·01
Multivariable adjusted‡ 0·64 0·47, 0·87 0·64 0·29, 1·41 1·00 0·75, 1·32
Strawberry consumption
Age adjusted 0·69 0·54, 0·89 0·49 0·29, 0·82 0·65 0·51, 0·81
Multivariable adjusted‡ 0·73 0·56, 0·95 0·72 0·41, 1·24 0·86 0·67, 1·10
Onion consumption
Age adjusted 0·84 0·65, 1·08 0·92 0·53, 1·62 1·00 0·78, 1·28
Multivariable adjusted‡ 0·83 0·64, 1·09 0·95 0·53, 1·70 1·05 0·81, 1·35
Pepper consumption
Age adjusted 0·78 0·63, 0·96 0·74 0·47, 1·17 0·58 0·47, 0·71
Multivariable adjusted‡ 0·80 0·64, 1·01 1·04 0·64, 1·71 0·67 0·54, 0·84
Red wine consumption
Age adjusted 0·60 0·46, 0·78 0·43 0·22, 0·82 0·57 0·44, 0·74
Multivariable adjusted‡ 0·53 0·39, 0·72 0·74 0·35, 1·58 0·65 0·48, 0·89
Tea consumption
Age adjusted 0·67 0·56, 0·81 0·62 0·43, 0·90 0·71 0·60, 0·85
Multivariable adjusted‡ 0·68 0·56, 0·82 0·70 0·48, 1·02 0·79 0·66, 0·95
* Total number of cancer mortalities is 887.
† Total number of CVD mortalities is 189.
‡ Multivariable adjusted model includes: age, BMI, smoking status, menopausal status, family history of diabetes, cancer and myocardial infarction, multivitamin supplement
use, Aspirin use, race, type 2 diabetes, hypercholesterolaemia, hypertension, physical activity, energy intake, alcohol consumption and the Alternative Health Eating Index
(minus alcohol) score.
§ Total number of mortalities from other causes is 818.
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Table 4. Association of quintiles of total-flavonoid and flavonoid-class consumption with risk of all-cause mortality
(Hazard ratios (HR) and 95% confidence intervals; n 93145)
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI Pfor trend
Total-flavonoid intake (mg/d) <138 138–<207 207–<308 308–<518 ≥518
Person-years 355 151 368 485 370 364 372 609 372295
Deaths (n) 433 390 323 351 397
Age adjusted 1·00 Ref. 0·85 0·74, 0·97 0·69 0·60, 0·80 0·73 0·63, 0·84 0·81 0·71, 0·93 0·10
Multivariable adjusted* 1·00 Ref. 0·96 0·84, 1·11 0·81 0·70, 0·94 0·86 0·74, 0·99 0·92 0·80, 1·06 0·59
Flavonol intake (mg/d) <9 9–<13 13–<17 17–<26 ≥26
Person-years 361 301 368 810 370 972 372 134 365687
Deaths (n) 398 347 345 356 448
Age adjusted 1·00 Ref. 0·83 0·71, 0·95 0·82 0·69, 0·92 0·80 0·69, 0·92 1·00 0·87, 1·14 0·030
Multivariable adjusted* 1·00 Ref. 0·90 0·78, 1·05 0·89 0·77, 1·04 0·88 0·76, 1·03 1·08 0·94, 1·25 0·006
Flavan-3-ol intake (mg/d) <12 12–<19 19–<39 39–<86 ≥86
Person-years 352 706 366 094 372 429 373 445 374230
Deaths (n) 428 399 335 335 397
Age adjusted 1·00 Ref. 0·88 0·77, 1·01 0·72 0·62, 0·83 0·71 0·62, 0·82 0·82 0·72, 0·94 0·30
Multivariable adjusted* 1·00 Ref. 0·99 0·86, 1·14 0·81 0·70, 0·94 0·79 0·69, 0·92 0·90 0·78, 1·03 0·30
Proanthocyanidin intake (mg/d) <79 79–<126 126–<200 200–<356 ≥356
Person-years 352 476 367 583 372 126 373 157 373562
Deaths (n) 435 400 327 331 401
Age adjusted 1·00 Ref. 0·87 0·76, 1·00 0·70 0·61, 0·81 0·69 0·60, 0·80 0·82 0·72, 0·94 0·78
Multivariable adjusted* 1·00 Ref. 0·98 0·85, 1·13 0·81 0·70, 0·94 0·80 0·69, 0·93 0·92 0·80, 1·05 0·42
Flavone intake (mg/d) <0·7 0·7–<1·1 1·1–<1·5 1·5–<2·2 ≥2·2
Person-years 362 321 371 169 371 600 371 692 362121
Deaths (n) 404 381 369 335 405
Age adjusted 1·00 Ref. 0·90 0·78, 1·03 0·84 0·73, 0·97 0·75 0·65, 0·86 0·89 0·77, 1·02 0·007
Multivariable adjusted* 1·00 Ref. 1·00 0·87, 1·16 1·00 0·87, 1·16 0·92 0·79, 1·07 1·11 0·96, 1·29 0·96
Flavanone intake (mg/d) <9 9–<17 17–<30 30–<51 ≥51
Person-years 360 666 370 612 373 056 372 588 361982
Deaths (n) 373 378 389 380 374
Age adjusted 1·00 Ref. 0·98 0·85, 1·13 0·98 0·85, 1·13 0·94 0·81, 1·08 0·92 0·80, 1·06 0·75
Multivariable adjusted* 1·00 Ref. 1·07 0·93, 1·24 1·11 0·96, 1·28 1·11 0·96, 1·28 1·11 0·97, 1·30 0·015
Anthocyanin intake (mg/d) <3 3–<5 5–<9 9–<17 ≥17
Person-years 354 483 368 366 374 278 373 382 368395
Deaths (n) 456 407 331 336 364
Age adjusted 1·00 Ref. 0·85 0·74, 0·97 0·67 0·58, 0·77 0·67 0·58, 0·77 0·71 0·62, 0·82 <0·001
Multivariable adjusted* 1·00 Ref. 0·96 0·84, 1·10 0·81 0·70, 0·94 0·85 0·73, 0·99 0·92 0·79, 1·08 0·10
Ref., referent values.
* Multivariable adjusted model includes: age, BMI, smoking status, menopausal status, family history of diabetes, cancer and myocardial infarction, multivitamin supplement use, Aspirin
use, race, type 2 diabetes, hypercholesterolaemia, hypertension, physical activity, energy intake, alcohol consumption and the Alternative Health Eating Index (minus alcohol) score.
Table 5. Multivariable-adjusted risk of mortality subtypes by total flavonoid and flavonoid class, comparing participants in the lowest
quintile of flavonoid intake (referent group) with those in the highest quintile
(Hazard ratios (HR) and 95% confidence intervals; n 93 145)
Cancer mortality* CVD mortality† Other cause‡
Quintile 5 Quintile 5 Quintile 5
HR 95% CI HR 95% CI HR 95% CI
Total flavonoid intake
Age adjusted 0·80 0·64, 0·98 0·66 0·43, 1·02 0·86 0·71, 1·05
Multivariable adjusted§ 0·84 0·67, 1·04 0·83 0·53, 1·29 1·03 0·84, 1·26
Flavonol intake
Age adjusted 0·98 0·80, 1·20 0·76 0·50, 1·16 1·08 0·88, 1·31
Multivariable adjusted§ 0·99 0·80, 1·24 0·91 0·58, 1·41 1·22 0·99, 1·51
Flavan-3-ol intake
Age adjusted 0·84 0·68, 1·04 0·64 0·42, 0·98 0·85 0·70, 1·04
Multivariable adjusted§ 0·87 0·70, 1·08 0·75 0·49, 1·16 0·96 0·78, 1·17
Proanthocyanidins intake
Age adjusted 0·86 0·70, 1·06 0·64 0·41, 0·99 0·83 0·68, 1·00
Multivariable adjusted§ 0·90 0·72, 1·11 0·77 0·49, 1·20 0·97 0·79, 1·18
Flavone intake
Age adjusted 0·89 0·72, 1·10 0·74 0·48, 1·16 0·91 0·75, 1·12
Multivariable adjusted§ 1·00 0·80, 1·06 1·15 0·72, 1·83 1·22 0·99, 1·51
Flavanone intake
Age adjusted 0·91 0·73, 1·13 0·81 0·51, 1·28 0·95 0·77, 1·18
Multivariable adjusted§ 1·03 0·83, 1·29 1·10 0·69, 1·76 1·21 0·97, 1·50
Anthocyanin intake
Age adjusted 0·74 0·59, 0·91 0·48 0·30, 0·78 0·74 0·61, 0·90
Multivariable adjusted§ 0·77 0·61, 0·98 0·85 0·50, 1·43 1·10 0·88, 1·37
* Total number of cancer mortalities is 887.
† Total number of CVD mortalities is 189.
‡ Total number of mortalities from other causes is 818.
§ Multivariable adjusted model includes: age, BMI, smoking status, menopausal status, family history of diabetes, cancer and myocardial infarction, multivitamin
supplement use, Aspirin use, race, type 2 diabetes, hypercholesterolaemia, hypertension, physical activity, energy intake, alcohol consumption and the
Alternative Health Eating Index (minus alcohol) score.
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opposed to a compound level, it is important to note that
ﬂavonoid-intake estimates are derived from intake data for
many different individual food items, the majority of which
were not included in our study, which only looked at
foods which contribute substantially to ﬂavonoid-class intake.
The importance of whole foods, as opposed to isolated
nutrients, are becoming increasingly recognised for public
health guidelines and dietary recommendations(35).
Although results were not substantially altered by conducting
sensitivity analyses, such as the lag analyses, it is important to note
that causality of observed relationships cannot be established
due to the observational nature of the study. Also, despite the
inclusion of dietary and lifestyle factors into statistical models,
residual or unmeasured confounders cannot be ruled out.
Identiﬁcation of causality is further limited by the complexity
associated with assessing food composition and dietary
intake including for ﬂavonoids(36), which further highlights
the importance of conducting both nutrient-based and whole-
food-based analyses.
In summary, in this prospective cohort study of female US
nurses, we found a beneﬁcial relationship between the dietary
intake of select whole-food sources of ﬂavonoids and risk of
mortality. Speciﬁcally, frequent consumption of blueberries,
strawberries, peppers, red wine and was associated with
reduced risk of all-cause mortality. These beneﬁcial associations
did not extend to total-ﬂavonoids or ﬂavonoid subclasses, and
when considering the literature as a whole, future prospective
association studies are warranted.
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